Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary Analysis of the REVELUTION Trial [0.03%]
他汀的使用可抑制亮丙瑞林相关冠状动脉粥样硬化的发展：来自REVELUTION试验的事后分析结果
Adithya K Yadalam,Chang Liu,Marly van Assen et al.
Adithya K Yadalam et al.
[Figure: see text] Keywords: androgen deprivation therapy; cancer survivorship; coronary artery disease; cor...
Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy [0.03%]
依普利姆 Мак/缬沙坦对乳腺癌治疗期间右心室和舒张功能的影响
Mari Nordbø Gynnild,Albulena Mecinaj Lilleaasen,Torgeir Wethal et al.
Mari Nordbø Gynnild et al.
[Figure: see text] Keywords: anthracycline; breast cancer; echocardiography; heart failure; prevention.
Do Platelets Explain Why GnRH Antagonists Are Potentially Safer From a Cardiovascular Perspective? [0.03%]
血小板能解释为什么GnRH拮抗剂从心血管角度看更安全吗？
Ye Deng,Yan Wang,Leilei Cheng
Ye Deng
[Figure: see text] Keywords: biomarkers; hormonal therapy; mechanisms; prevention; prostate cancer; risk fac...
Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome [0.03%]
促性腺激素释放激素类似物和拮抗剂对血小板活性和转录组的分歧效应
Antonia Beitzen-Heineke,Matthew Siskin,Matthew Muller et al.
Antonia Beitzen-Heineke et al.
Background: Prostate cancer is associated with increased cardiovascular risk. Among androgen deprivation therapy (ADT) modalities, the gonadotropin-releasing hormone (GnRH) antagonist relugolix appears to confer a lower r...
The Cardiometabolic-to-Cancer Axis: Molecular Insights From Cardio-Kidney-Metabolic Syndrome Staging [0.03%]
从心血管-肾脏-代谢病分期中获得的关于心代谢物-癌症轴的分子见解
Adithya K Yadalam,Yan V Sun
Adithya K Yadalam
[Figure: see text] Keywords: Olink; UK Biobank; cancer; cardio-kidney-metabolic; cardio-oncology; cardiovasc...
Hemoglobin Decline and Occult Cancer After OAC Initiation: "No Smoke Without Fire?" [0.03%]
利伐沙班等新型口服抗凝药使用后血红蛋白下降及隐源性癌症：“无风不起浪”？
Joong Min Lee,Min Soo Cho,Duk-Woo Park
Joong Min Lee
[Figure: see text] Keywords: arrhythmia; gastrointestinal cancer; outcomes.
Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients With Atrial Fibrillation [0.03%]
房颤患者开始口服抗凝后血红蛋白下降及随后的癌症检出率
Pil-Sung Yang,Jee Hyuk Byun,Hanjin Park et al.
Pil-Sung Yang et al.
Background: Previous studies evaluating cancer risk during oral anticoagulation (OAC) have focused on overt bleeding events, whereas the significance of hemoglobin (Hb) decline in the absence of clinically overt bleeding ...
The Quest for a Safer Use of Anthracyclines Continues: Risk Prediction of Clinical Cardiotoxicity [0.03%]
蒽环类药物安全使用的探索之路——临床心毒性风险预测模型的构建及验证
Alberto A Gabizon,Joshua E Levenson
Alberto A Gabizon
[Figure: see text] [Figure: see text] Keywords: anthracycline; cardiomyopathy; echocard...
Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations: JACC: CardioOncology Primer [0.03%]
抗体偶联药物的心血管毒性：当前证据和不断演变的考虑因素：JACC心脏肿瘤学入门文章
Heather Moore,Laura A Huppert,Javid J Moslehi et al.
Heather Moore et al.
[Figure: see text] Keywords: HER2-directed therapy; antibody-drug conjugates; breast cancer; cardiac surveil...
Cerebrovascular Accident Risk in Survivors of Head and Neck Cancer: JACC CardioOncology State-of-the-Art Review [0.03%]
头颈部癌症幸存者中脑血管病风险：JACC心脏肿瘤学进展综述
Courtney Pisano,Jenica Upshaw,Benjamin Colvard et al.
Courtney Pisano et al.
Head and neck cancer survivors treated with radiation therapy have a substantially higher long-term risk of cerebrovascular accident than the general population, driven by radiation-related carotid artery injury, baseline cardiovascular ris...